Abstract
Antiphospholipid antibodies are a heterogenous group of autoantibodies directed against glycoproteins in concert with anionic phospholipids. In clinical laboratory practice, antiphospholipid antibody evaluations usually consist of a combination of the following: anticardiolipin antibody assay, anti-beta 2 glycoprotein I assay, and at least two lupus anticoagulant assays with an appropriate confirmatory test. Lupus anticoagulants produce their laboratory effect by prolonging recalcification times in assays within which phospholipid content is limited. Although many assays are available, all are based on the fundamental principle of demonstrating normalization of prolonged recalcification times with the addition of exogenous phospholipid. The antibody specificity of an individual lupus anticoagulant is difficult or impossible to determine; however a small proportion do demonstrate avidity for selected proteins such as prothrombin or beta 2 glycoprotein I. The mechanism by which these antibodies cause their clinical manifestations remains unknown; however their relationship to increased risk of thrombosis, pregnancy loss, and autoimmune thrombocytopenia is undoubted. There is no correlation between the “strength” of lupus anticoagulants and the level of thrombotic risk; thus it is important to identify both “weak” and “strong” lupus anticoagulants.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abo SM, DeBari VA (2007) Review: laboratory evaluation of the antiphospholipid syndrome. Ann Clin Lab Sci 37:3–14
Triplett DA (2002) Antiphospholipid antibodies. Arch Pathol Lab Med 126:1424–1429
Pengo V, Biasiolo A, Gresele P, Marongiu F, Erba N, Veschi F, Ghirarduzzi A, De Candia E, Montaruli B, Testa S, Barcellona D, Tripodi A, on behalf of Participating Centres of Italian Federation of Thrombosis Centres (FCSA) (2007) Survey of lupus anticoagulant diagnosis by central evaluation of plasma samples. J Thromb Haemost 5:925–30
Lim W, Crowther MA, Eikleboom JW (2006) Management of antiphospholipid antibody syndrome: a systematic review. JAMA 295:1050–1057
Brandt JT, Triplett DA, Alving B, Scharrer I (1995) Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on lupus anticoagulant/antiphospholipid antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 74:1185–90
Tripodi A (2007) Laboratory testing for lupus anticoagulants: a review of issues affecting results. Clin Chem 53:1629–1635
Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RHWM, de Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krills SA (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thrombo Haemost 4:295–306
Jennings I, Greaves M, Mackie IJ, Kitchen S, Woods TAL, Preston FE (2002) Lupus anticoagulant testing: improvements in performance in a UK NEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods. Br J Haematol 119:364–369
Jennings I, Mackie I, Arnout J, Preston FE, on behalf of the UK National External Quality Assessment Scheme for Blood Coagulation (2004) Lupus anticoagulant testing using plasma spiked with monoclonal antibodies: performance in the UK NEQAS proficiency testing programme. J Thromb Haemost 2:2178–84
Teruya J, West AG, Suell MN (2007) Lupus anticoagulant assays: questions answered and to be answered. Arch Pathol Lab Med 131:885–889
Pierangeli S, Harris EN (2005) Review: clinical laboratory testing for the antiphospholipid syndrome. Clinica Chimica Acta 357:17–33
Clinical and Laboratory Standards Institute/NCCLS (June 2000) How to define and determine reference intervals in the clinical laboratory; approved guideline. 2nd edn. CLSI/NCCLS document C28-A2. Clinical and Laboratory Standards Institute, Wayne (PA).
Clinical and Laboratory Standards Institute/NCCLS (June 2003) Collection, transport, and processing of blood specimens for testing plasma-based coagulation assays; approved guideline. 4th edn. CLSI/NCCLS document H21-A4. Clinical and Laboratory Standards Institute, Wayne (PA).
Clinical and Laboratory Standards Institute/NCCLS (June 1997) Determination of factor coagulant activities; approved guideline. CLSI/NCCLS document H48-A. Clinical and Laboratory Standards Institute, Wayne (PA).
Clinical and Laboratory Standards Institute/NCCLS (June 2006) Preparation and testing of reagent water in the clinical laboratory; approved guideline. 4th edn. CLSI/NCCLS document C3–A4. Clinical and Laboratory Standards Institute, Wayne (PA).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Humana Press
About this protocol
Cite this protocol
Moffat, K., Raby, A., Crowther, M. (2013). Lupus Anticoagulant Testing. In: Monagle, P. (eds) Haemostasis. Methods in Molecular Biology, vol 992. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-339-8_7
Download citation
DOI: https://doi.org/10.1007/978-1-62703-339-8_7
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-338-1
Online ISBN: 978-1-62703-339-8
eBook Packages: Springer Protocols